Page 1 of 1
| Politician | Branch | Asset | Ticker | Category | Type | Transaction Date | Amount | Filing Date |
|---|---|---|---|---|---|---|---|---|
| Donald J Trump | executive | CATALYST PHARMACEUTICALS | CPRX | STOCK | purchase | March 4, 2026 | $$15,001 - $50,000 | May 14, 2026 |
| Christopher Landau | executive | Royalty Pharma plc Class A Ordinary Shares (RPRX) | RPRX | STOCK | Sale | April 28, 2025 | $$100,001 - $250,000 | July 16, 2025 |
| Michael T. McCaul | house | PROSUS NV | PRX | STOCK | PURCHASE | March 18, 2025 | $$1,001 - $15,000 | April 17, 2025 |
| Michael T. McCaul | house | PROSUS NV | PRX | STOCK | PURCHASE | March 11, 2025 | $$1,001 - $15,000 | April 17, 2025 |
| Donald J Trump | executive | CATALYST PHARMACEUTICALS | CPRX | STOCK | purchase | Jan. 6, 2025 | $$15,001 - $50,000 | May 14, 2026 |
| Michael T. McCaul | house | PROSUS NV | PRX | STOCK | PURCHASE | Aug. 27, 2024 | $$1,001-15,000 | Sept. 16, 2024 |
| Michael T. McCaul | house | PROSUS INC | PRX | STOCK | PURCHASE | April 15, 2024 | $$1,000-$15,000 | May 11, 2024 |
| Christine Abizaid | executive | USAA 500 Index Fund Reward Shares (USPRX) | USPRX | FUND | Sale | Dec. 22, 2023 | $$100,001 - $250,000 | April 5, 2024 |
| C. Scott Franklin | house | Fidelity Money Market Fund - Premium Class [CS] | FPRXX | FUND | Sale | Sept. 11, 2023 | $$50,001 - $100,000 | Oct. 12, 2023 |
| Stacey Dixon | executive | ROYALTY PHARMA PLC SHS CLASS A (RPRX) | RPRX | STOCK | Sale | Aug. 23, 2021 | $$1,001 - $15,000 | Aug. 31, 2021 |
| Stacey Dixon | executive | RPRX - ROYALTY PHARMA PLC SHS CLASS A | RPRX | STOCK | Purchase | July 16, 2021 | $$1,001 - $15,000 | Aug. 28, 2021 |
| Stacey Dixon | executive | RPRX - ROYALTY PHARMA PLC SHS CLASS A | RPRX | STOCK | Sale | June 15, 2021 | $$1,001 - $15,000 | Aug. 28, 2021 |
| Mitchell M Zais | executive | AQR Style Premia Alternative Fund Class R6 Shares (QSPRX) | QSPRX | FUND | Purchase | Sept. 14, 2020 | $$1,001 - $15,000 | Dec. 11, 2020 |
| Mitchell M Zais | executive | AQR Style Premia Alternative Fund Class R6 Shares (QSPRX) | QSPRX | FUND | Purchase | April 24, 2020 | $$1,001 - $15,000 | Dec. 11, 2020 |
| Donald J Trump | executive | CATALYST PHARMACEUTICALS | CPRX | STOCK | sale | Feb. 26, 2020 | $Yes $15,001 - $50,000 | May 14, 2026 |
| Carlos Curbelo | house | PaREXEL International Corporation (PRXL) | PRXL | STOCK | Sale | April 5, 2017 | $$1,001 - $15,000 | June 1, 2017 |
| Carlos Mr Curbelo | house | PAREXEL International Corporation (PRXL) | PRXL | STOCK | Purchase | Dec. 30, 2016 | $$1,001 - $15,000 | Jan. 10, 2017 |
| Pete Sessions | house | PaREXEl International Corporation (PRXl) | PRXL | STOCK | S | Dec. 21, 2016 | $$15,001 - $50,000 | Dec. 23, 2016 |
| James B. Renacci | house | PRAXAR INCORPORATED (PRX) | PRX | STOCK | PURCHASE | June 28, 2016 | $$15,001 - $50,000 | July 6, 2016 |
| James B. Renacci | house | PRAVAX INCORPORATED (PRX) | PRX | STOCK | Purchase | June 8, 2016 | $$15,001 - $50,000 | June 17, 2016 |
| James B. Renacci | house | PRAIRIE INCORPORATED (PRX) | PRX | STOCK | Purchase | Dec. 9, 2015 | $$15,001 - $50,000 | Dec. 21, 2015 |